Dividend Aristocrats are firms with a track record of increasing shareholder payouts for at least 25 consecutive years. They should be distinguished from Dividend Kings which have a 50 year track record.
Johnson & Johnson is well-diversified across three sectors, and none of them—pharma, medical technology, and consumer staples—perform particularly poorly under any given set of circumstances.